HealthTech M&A predictions: UK and Europe next 12 months

Lloyd Price
1 hour ago
5 min read

HealthTech M&A predictions: UK and Europe next 12 months

HealthTech M&A in the UK and Europe over the next 12 months (May 2025–May 2026) is set to remain robust, driven by evolving market dynamics, regulatory shifts, and technological advancements. Here’s a focused prediction based on current trends and regional factors:

Key Drivers and Predictions:

Regulatory Tailwinds Boosting Activity

The UK’s Competition and Markets Authority (CMA) has shifted toward a more deal-friendly stance, favouring conditional approvals over outright blocks. This is expected to encourage M&A in HealthTech, particularly in digital health and medtech, where competition concerns have historically been higher. Falling interest rates across the UK and Eurozone will also lower financing costs, making acquisitions more attractive for both strategic and financial buyers.

Focus on Digital Health and AI

European companies will prioritise acquiring digital health startups and AI-driven solutions to enhance patient outcomes and operational efficiency. High-demand areas include telemedicine, remote patient monitoring (RPM), and AI-powered diagnostics. For instance, the integration of AI into healthcare is accelerating, with companies like Microsoft hiring HealthTech founders to bolster their AI divisions, signalling a broader trend of tech giants entering the space.

Cross-Border Consolidation

The European Single Market will facilitate cross-border M&A, allowing UK and European firms to scale operations and access larger markets. Expect increased activity as companies seek to acquire complementary capabilities, particularly in health IT and medical devices. This aligns with the trend of European firms partnering with US players to tap into advanced technologies and patient populations.

Private Equity and Venture Capital Surge

PE and VC firms will remain key players, driving M&A through platform acquisitions and bolt-on deals. The maturing HealthTech market will see consolidation, with larger firms acquiring niche players in areas like mental health tech and digital therapeutics. Recent UK deals, such as Patchwork Health’s acquisition of L2P Enterprise Ltd., highlight this trend toward workforce management and operational efficiency solutions.

Cybersecurity and GDPR Compliance as Deal Catalysts

With cybersecurity threats intensifying in healthcare, GDPR compliance will be a major driver of M&A in Europe. Companies with expertise in data privacy and security will be prime targets, as larger firms look to bolster their capabilities to meet regulatory demands and protect patient data.

Sector-Specific Hotspots

Telehealth and RPM: Continued demand for scalable, cost-effective care delivery will drive acquisitions of telehealth platforms and RPM solutions.

Mental Health Tech: Rising demand for digital mental health tools, such as teletherapy platforms, will attract buyers.

Preventive Care: The shift toward preventive care will fuel acquisitions of startups focused on early detection and wellness, especially in the UK, where staffing shortages are pushing innovation in care delivery.

Challenges to Watch

Antitrust Scrutiny: Despite a more lenient UK approach, broader EU antitrust concerns could slow some cross-border deals, especially if member states fail to align on foreign direct investment rules.

Economic Uncertainty: While inflation has cooled, global economic volatility could still impact deal confidence, particularly for smaller HealthTech firms reliant on VC funding.

Takeaways for Founders

Position for Acquisition: Emphasise scalability, regulatory compliance (e.g., GDPR), and niche expertise in high-growth areas like AI or mental health.

Leverage Cross-Border Opportunities: Look for strategic buyers in both the UK and Europe to maximise deal value.

Prepare for PE Interest: With PE firms flush with capital, ensure your startup demonstrates strong revenue potential and operational efficiency to attract investment.

Most in demand sub-sectors in HealthTech > M&A predictions in UK and Europe for next 12 months

Based on current trends and predictions for the next 12 months (May 2025 - May 2026) in the UK and European HealthTech M&A landscape, the following sub-sectors are anticipated to be most in demand:

Digital Health Platforms & Solutions

Companies offering integrated digital health platforms with broad functionality are highly attractive. The NHS and European healthcare systems increasingly prefer comprehensive solutions over fragmented ones.

This includes platforms facilitating virtual consultations, remote patient monitoring, and chronic disease management.

Examples include companies providing digital front doors for patient engagement and those streamlining workflows for healthcare providers.

Artificial Intelligence (AI) and Data Analytics

AI-driven solutions for diagnostics, patient engagement, operational efficiency, and drug discovery are expected to see significant investment and M&A activity.

Companies specialising in AI-powered medical diagnostics, particularly in areas like radiology and pathology, are in demand.

Solutions leveraging data analytics for personalised treatment strategies and smarter resource allocation within healthcare systems will also be key targets.

Remote Patient Monitoring (RPM) and Wearable Technology

With the increasing focus on care outside of hospitals and proactive healthcare, companies offering sophisticated RPM technologies and advanced wearable devices for health management are gaining traction.

These technologies aid in chronic disease management, early detection, and reducing hospital readmissions.

Digital Therapeutics

Solutions offering digital interventions for managing and treating medical conditions, including mental health, are expected to attract investor interest as healthcare systems look for scalable and accessible therapeutic options.

HealthTech focused on Integrated Care

Companies that facilitate the breaking down of traditional silos in healthcare, particularly in areas like healthcare interpretation and patient communication across integrated care systems (ICSs), are likely to be in demand.

Cybersecurity in Healthcare

With the increasing digitisation of healthcare, robust cybersecurity solutions to protect patient data are paramount, making companies in this sub-sector attractive targets.

General Trends Influencing HealthTech M&A

Consolidation: The HealthTech market is maturing, moving from a surge of startups to a consolidation phase where stronger players are merging to offer more comprehensive solutions and achieve scale within healthcare systems like the NHS.

Private Equity Interest: Private equity firms have significant under deployed capital and are actively seeking opportunities in HealthTech, attracted by the sector's relatively stable returns. They are backing roll-ups to create larger, more impactful organizations.

Strategic Acquisitions by Corporates: Large healthcare and technology corporations, both from the US and Europe, are showing increased interest in acquiring innovative HealthTech companies to enhance their capabilities and market reach.

Government Policy and Funding: Government initiatives and increased funding for digital transformation in healthcare, such as the NHS's technology and digital improvement budgets, are incentivizing investment and M&A in relevant technology areas. The focus on moving care to community settings, digital transition, and preventative care drives demand for technologies supporting these shifts.

Value-Based Care: While investment in traditional value-based care models faced challenges, technologies enabling efficiency and cost savings, aligning with value-based procurement frameworks, will be attractive.

Patent Cliff in Pharma: The pharmaceutical industry's need to replenish pipelines due to patent expirations is driving acquisitions of biotech and HealthTech companies with promising late-stage assets and innovative drug design technologies.

In summary, the HealthTech M&A landscape in the UK and Europe over the next 12 months is expected to be dynamic, with significant interest in digital health platforms, AI and data analytics, remote monitoring, digital therapeutics, and solutions enabling integrated care and cybersecurity. Consolidation and strategic acquisitions, driven by both corporate and private equity players and influenced by government policies, will shape the market.

Nelson Advisors > Healthcare Technology M&A

Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

We share our views on the latest Healthcare Technology mergers, acquisitions and partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide